Case Control Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 109-119
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.109
Table 2 Allele and genotype frequencies of interferon lambda-4 rs12979860 polymorphism in patients with hepatitis C virus-associated liver diseases and healthy control subjects
rs12979860
Control, n = 260
Total patients, n = 305
Fibrosis, n = 53
Cirrhosis, n = 154
HCC, n = 98
P value






Fibrosis vs Control
Cirrhosis vs Control
HCC vs Control
Fibrosis vs Cirrhosis
Cirrhosis vs HCC
Allele0.047< 0.0010.0100.7080.618
C345 (66.3)331 (54.3)59 (55.7)163 (52.9)109 (55.6)
T175 (33.7)279 (45.7)47 (44.3)145 (47.1)87 (44.4)
Genotype0.113< 0.0010.0020.5410.665
CC115 (44.2)76 (24.9)16 (30.2)36 (23.4)24 (24.5)
CT115 (44.2)179 (58.7)27 (50.9)91 (59.1)61 (62.2)
TT30 (11.6)50 (16.4)10 (18.9)27 (17.5)13 (13.3)